Patient acceptance of fluorescent and reflective spectroscopy as a replacement test for the pap smear

Daron Gale Ferris, Eileen D. Dickman, Mark S. Litaker, Kelly M. Smith, Lynn M. Allmond, Terry L. Arrington

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective. To determine women's acceptance of fluorescent and reflective spectroscopy (FRS) as a potential replacement test for the Pap smear. Materials and methods. Women scheduled for a colposcopic examination, or a colposcopic and FRS examination, completed a 22-item questionnaire that included demographic data, medical history, and preference-type questions. Data were compared using Χ2 and Wilcoxon's rank sum tests. Results. Women considered accuracy, comfort, and quick results to be the most important characteristics for new cervical cancer tests. Immediate test results were preferred strongly by both groups (control, 84.5%; scanned, 88.6%). Provided FRS was more accurate than the Pap smear, most women (control, 74.7%; scanned, 68.2%) would rather have FRS if it cost the same as a Pap smear. Conclusions. Women consider accuracy, comfort, and time critical issues with respect to FRS used as a primary screening test. Acceptance of this new technology will be facilitated by designing equipment accordingly to satisfy the concerns of women.

Original languageEnglish (US)
Pages (from-to)294-298
Number of pages5
JournalJournal of Lower Genital Tract Disease
Volume7
Issue number4
DOIs
StatePublished - Oct 1 2003

Fingerprint

Papanicolaou Test
Spectrum Analysis
Nonparametric Statistics
Uterine Cervical Neoplasms
Demography
Technology
Costs and Cost Analysis
Equipment and Supplies
Control Groups

Keywords

  • Cervical neoplasia
  • Fluorescent and reflective spectroscopy
  • Patient acceptance

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Patient acceptance of fluorescent and reflective spectroscopy as a replacement test for the pap smear. / Ferris, Daron Gale; Dickman, Eileen D.; Litaker, Mark S.; Smith, Kelly M.; Allmond, Lynn M.; Arrington, Terry L.

In: Journal of Lower Genital Tract Disease, Vol. 7, No. 4, 01.10.2003, p. 294-298.

Research output: Contribution to journalArticle

Ferris, Daron Gale ; Dickman, Eileen D. ; Litaker, Mark S. ; Smith, Kelly M. ; Allmond, Lynn M. ; Arrington, Terry L. / Patient acceptance of fluorescent and reflective spectroscopy as a replacement test for the pap smear. In: Journal of Lower Genital Tract Disease. 2003 ; Vol. 7, No. 4. pp. 294-298.
@article{ee69c879e777409086552482e6841bbe,
title = "Patient acceptance of fluorescent and reflective spectroscopy as a replacement test for the pap smear",
abstract = "Objective. To determine women's acceptance of fluorescent and reflective spectroscopy (FRS) as a potential replacement test for the Pap smear. Materials and methods. Women scheduled for a colposcopic examination, or a colposcopic and FRS examination, completed a 22-item questionnaire that included demographic data, medical history, and preference-type questions. Data were compared using Χ2 and Wilcoxon's rank sum tests. Results. Women considered accuracy, comfort, and quick results to be the most important characteristics for new cervical cancer tests. Immediate test results were preferred strongly by both groups (control, 84.5{\%}; scanned, 88.6{\%}). Provided FRS was more accurate than the Pap smear, most women (control, 74.7{\%}; scanned, 68.2{\%}) would rather have FRS if it cost the same as a Pap smear. Conclusions. Women consider accuracy, comfort, and time critical issues with respect to FRS used as a primary screening test. Acceptance of this new technology will be facilitated by designing equipment accordingly to satisfy the concerns of women.",
keywords = "Cervical neoplasia, Fluorescent and reflective spectroscopy, Patient acceptance",
author = "Ferris, {Daron Gale} and Dickman, {Eileen D.} and Litaker, {Mark S.} and Smith, {Kelly M.} and Allmond, {Lynn M.} and Arrington, {Terry L.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1097/00128360-200310000-00012",
language = "English (US)",
volume = "7",
pages = "294--298",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Patient acceptance of fluorescent and reflective spectroscopy as a replacement test for the pap smear

AU - Ferris, Daron Gale

AU - Dickman, Eileen D.

AU - Litaker, Mark S.

AU - Smith, Kelly M.

AU - Allmond, Lynn M.

AU - Arrington, Terry L.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Objective. To determine women's acceptance of fluorescent and reflective spectroscopy (FRS) as a potential replacement test for the Pap smear. Materials and methods. Women scheduled for a colposcopic examination, or a colposcopic and FRS examination, completed a 22-item questionnaire that included demographic data, medical history, and preference-type questions. Data were compared using Χ2 and Wilcoxon's rank sum tests. Results. Women considered accuracy, comfort, and quick results to be the most important characteristics for new cervical cancer tests. Immediate test results were preferred strongly by both groups (control, 84.5%; scanned, 88.6%). Provided FRS was more accurate than the Pap smear, most women (control, 74.7%; scanned, 68.2%) would rather have FRS if it cost the same as a Pap smear. Conclusions. Women consider accuracy, comfort, and time critical issues with respect to FRS used as a primary screening test. Acceptance of this new technology will be facilitated by designing equipment accordingly to satisfy the concerns of women.

AB - Objective. To determine women's acceptance of fluorescent and reflective spectroscopy (FRS) as a potential replacement test for the Pap smear. Materials and methods. Women scheduled for a colposcopic examination, or a colposcopic and FRS examination, completed a 22-item questionnaire that included demographic data, medical history, and preference-type questions. Data were compared using Χ2 and Wilcoxon's rank sum tests. Results. Women considered accuracy, comfort, and quick results to be the most important characteristics for new cervical cancer tests. Immediate test results were preferred strongly by both groups (control, 84.5%; scanned, 88.6%). Provided FRS was more accurate than the Pap smear, most women (control, 74.7%; scanned, 68.2%) would rather have FRS if it cost the same as a Pap smear. Conclusions. Women consider accuracy, comfort, and time critical issues with respect to FRS used as a primary screening test. Acceptance of this new technology will be facilitated by designing equipment accordingly to satisfy the concerns of women.

KW - Cervical neoplasia

KW - Fluorescent and reflective spectroscopy

KW - Patient acceptance

UR - http://www.scopus.com/inward/record.url?scp=0242320549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242320549&partnerID=8YFLogxK

U2 - 10.1097/00128360-200310000-00012

DO - 10.1097/00128360-200310000-00012

M3 - Article

C2 - 17051087

AN - SCOPUS:0242320549

VL - 7

SP - 294

EP - 298

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 4

ER -